Adjuvant arthritis is an experimental disease of rats induced by immunization to antigens of Mycobacterium tuberculosis. Our observation that arthritis could be induced in irradiated rats by the A2 line of T lymphocytes in the absence of mycobacterial antigens suggested that adjuvant arthritis is an autoimmune disease. Moreover, the A2 line could be used to vaccinate unirradiated rats against the subsequent induction of adjuvant arthritis by active immunization to Mycobacteia. In the present study we found that thymus cells obtained from A2 vaccinated rats could transfer resistance to adjuvant arthritis to naive rats. This indicates that the mechanism of resistance induced by A2 vaccination is probably immunological and involves thymus-derived lymphocytes.
Introduction
Adjuvant arthritis (AA)' can be induced in rats by an intradermal injection of killed Mycobacterium tuberculosis (MT) in oil in the form of complete Freund's adjuvant (CFA) (1) . AA presents some of the clinical and pathological features of rheumatoid arthritis and has been considered as a model of the human disease (2) . From rats immunized with CFA, we have isolated the A2 line of T lymphocytes by virtue of its proliferative response to MT (3) . The A2 line cells could induce arthritis following intravenous injection into irradiated recipient rats, which suggests that AA may be caused by an autoimmune attack against joint antigens that are cross-reactive with MT (4) . Moreover, A2 line cells could be used to vaccinate unirradiated recipient rats against attempts to induce active AA by subsequent inoculation with CFA (3) .
In the studies reported here, we undertook to characterize the mechanisms involved in A2 line-induced vaccination against AA Received for publication 21 June 1984 and in revised form 18 September 1984.
1. Abbreviations used in this paper: AA, adjuvant arthritis; BP, basic protein; CFA, complete Freund's adjuvant; Con A, concanavalin A; EAE, experimental autoimmune encephalomyelitis; EAT, experimental autoimmune thyroiditis; MT, Mycobacterium tuberculosis; OA, ovalbumin. thymus or spleen required for the vaccination effect; and can line-induced vaccination be adoptively transferred to naive rats?
Methods
Rats. Inbred Lewis rats were obtained from the Animal Breeding Center of this Institute. Unless otherwise stated, 2-mo-old female rats were used throughout the study.
Antigens. Heat-killed M. tuberculosis H37 Ra was purchased from Difco Laboratories (Detroit, MI). The bacteria were ground with a mortar and pestle under sterile conditions, and suspended either in incomplete Freund's adjuvant to prepare CFA, or in phosphatebuffered saline (PBS) to prepare MT antigen for in vitro experiments. A water soluble preparation of MT was made by suspending 100 mg of ground MT in double-distilled water for 48 h at 4VC with constant stirring. Suspended MT fragments were removed from the water by centrifugation twice at 2,000 rpm for 25 min. The supernatant containing a water soluble fraction of MT was lyophilized and stored at -20'C. Before use, the water soluble MT fraction was dissolved in PBS. This material was used only in the experiment shown in Table  III . Concanavalin A (Con A) was purchased from Bio-Yeda (Rehovot, Israel) and ovalbumin (OA) from Sigma Chemical Co., St. Louis, MO. Guinea pig basic protein of myelin (BP) was prepared as described (5) .
Culture medium. All cell cultures used Dulbecco's modification of Eagle's medium (Gibco Laboratories, Grand Island, NY). Medium used for restimulation (proliferation medium) was supplemented with I mM glutamine (Bio-Lab, Jerusalem, Israel), 2-mercaptoethanol (5 X l0-5 M), gentamycin (40 gg/ml), and 1% fresh autologous rat serum. The medium used to maintain the propagated cell lines and clones in long-term culture (propagation medium) was the proliferation medium supplemented with 15% (vol/vol) of supernatant of Con Astimulated mouse splenocytes as a source of T cell growth factor (5), 10% horse serum (Gibco Laboratories), I mM sodium pyruvate, and nonessential amino acids (Bio-Lab).
Line cells. Line A2 reactive to MT was isolated and maintained as described (3 (6) or against experimental autoimmune thyroiditis (EAT) (7). The lymphoblasts were collected, separated from residual accessory cells and from cellular debris by density gradients in some experiments (see Table I ), washed twice in PBS, and injected in 1 ml of PBS into the tail vein of nonirradiated Lewis rats. In some experiments (see Table I ), control rats were inoculated with irradiated thymus accessory cells that had been incubated for 3 d with MT Table I , inoculation of I X 106 cells had no effect, 5 X 106 cells produced a moderate decrease in clinical severity, while 10 X 106 cells caused a marked decrease in both incidence and severity of disease. Complete protection against AA was achieved by vaccination with 20 X 106 line A2 cells.
Time of onset and duration of vaccination. The time required for line-induced protection to be generated was assessed by challenging recipients of 2 X 107 A2 cells with CFA at various intervals after inoculating the cells. Table II shows that while some degree of protection was found 3 d after inoculating 2 X 107 A2 cells, full protection was found from the 16th d on, and persisted for at least 180 d.
MT carry-over is not responsible for vaccination. It has been shown that administration of small doses of MT antigens 4 wk, and some rats were inoculated with 2 X I07 A2 cells 45 d later. To assay susceptibility to AA, all the rats were challenged with CFA 80 days after surgery. Table IV tabulates the results which illustrate two findings. First, regarding rats that had not been vaccinated with A2 line cells, splenectomy had no influence on the susceptibility of the rats to AA, while adult thymectomy either alone or in combination with splenectomy hastened the onset Late thymectomy of vaccinated rats abolishes resistance to AA. Despite successful vaccination of thymectomized rats, the finding that thymus cells of vaccinated rats could transfer resistance to AA suggested that the thymus might house the cells responsible for resistance after they were induced. We therefore vaccinated 1-mo-old rats by inoculating them with A2 or control Cla (anti-ovalbumin) line cells, and then removed the thymus 3 or 35 d later. 45 d after the thymectomy, the rats were challenged with CFA to test their resistance to AA. Table V shows that recipients of Cla line cells were susceptible to induction of AA whether they were or were not thymectomized. In contrast, the rats that had been inoculated with A2 line cells were resistant to AA provided that they had been sham thymectomized or thymectomized only 3 d after vaccination. However, rats that had been thymectomized 35 d after vaccination with A2 line cells manifested a high incidence of severe arthritis. Therefore, late thymectomy led to loss of acquired resistance to AA. Hence, the cells responsible for acquired resistance could be generated in the absence of the thymus, but, given a thymus, they seemed to be housed there.
Discussion
Resistance to active induction of autoimmune disease is achievable by inoculating experimental subjects with cells of long term lines of T lymphocytes specifically reactive against the relevant antigens. We have called this phenomenon vaccination by its analogy to the use of attenuated microbial pathogens to induce specific resistance (10) . Vaccination has been successful in three experimental diseases: EAE, EAT, and AA.
For example, inoculation of rats with anti-BP lines produced EAE, and inoculation of mice with anti-thyroglobulin lines produced EAT. However, upon irradiation (1,500 rad), the line cells no longer mediated disease, but animals receiving a single inoculation of cells acquired resistance to induction of EAE by immunization with BP (9) or to induction of EAT by immunization with thyroglobulin (7). In the case of linemediated AA, arthritis was produced by A2 line cells only in recipients that had been irradiated (750 rad), and therefore to avoid disease it was not necessary to irradiate the A2 line, but only to desist from irradiating the recipient rats (3) . Why line A2 mediates arthritis in irradiated but not in intact rats is not known. It has been shown that irradiation augments the severity of actively induced AA (11) and that some rats subjected to total lymphoid irradiation spontaneously develop arthritis (12). Therefore, it is conceivable that natural mechanisms of resistance to AA and to line-induced arthritis exist in intact rats, and that these mechanisms can be neutralized by irradiation. Hence, vaccination might work by strengthening these mechanisms. The point of this report, however, is that induced resistance is associated with the thymus and can be transferred.
Whether or not AA is an autoimmune disease has been a controversial question. Several hypotheses have been proposed: that the arthritis results from an immune response to Mycobacterial antigens settling in the joints after immunization with CFA (13) ; that the physical injection of CFA sensitizes the rat to endogenous connective tissue antigens in the skin (14) ; or that there exists cross-reactivity between antigenic determinants of Mycobacteria and antigens in the joints (15) . The induction of arthritis using anti-MT line cells in the absence of CFA injection supports the latter hypothesis (4). We are presently characterizing the self-antigen that is the target of the immune attack on the joints, but as yet can only say that it is probably not collagen type 11 (4) .
In the present study we investigated factors involved in the (Table I) , and required time to become established (Table II) . We have observed that resistance to AA becomes solid by -10 d after inoculation of A2 line cells. Once it sets in, resistance seemed to persist (Table II) . As illustrated in Table III , vaccination could not be explained by possible carryover of MT antigens. Line A2 did not need to be incubated with MT to induce resistance, and incubation of clone A2b or of thymus accessory cells alone with MT did not produce vaccination. Moreover, A2 line cells were as effective after incubation with water soluble MT as they were after incubation with particulate MT. The importance of the thymus in vaccination was indicated by the transfer of resistance by thymus cells and not by spleen cells or serum obtained from vaccinated rats (Figs. 1 and 2) . In this study, transfer of vaccination was successful when the recipient rats were irradiated with 150 rad. Transfer was unsuccessful when the recipients were not irradiated (not shown). Why lymphocyte transfer is enhanced by mild irradiation is unknown, but several mechanisms have been proposed including the creation of "space" in lymphoid organs by depletion of recipient lymphocytes (16) .
Vaccination has been shown to be antigen-specific in AA (3), EAE (17) , and EAT (7), and its transfer by thymus cells, probably T lymphocytes, suggests that resistance is mediated by an immunological mechanism. We have found that the specificity of vaccination was directed by the fine specificity of the line cells used for vaccination, which suggests the possibility that the antigen-specific line cells immunized the recipients against the receptors needed to recognize the self-antigens critical for the autoimmune disease (17) . Although anti-receptor or anti-idiotypic immunity might serve to regulate autoimmunity (18, 19) , other mechanisms are conceivable and the question remains to be resolved. For example, clone A2b, although arthritogenic, could not vaccinate against AA (4), and several encephalitogenic clones have been isolated that do not vaccinate against EAE (in preparation). Be that as it may, the present study shows that the thymus can be involved in acquired resistance to autoimmunity. However, the role of the thymus in this resistance, although major, was not exclusive. Vaccination against AA could be obtained in rats that had been thymectomized, even though adult thymectomy seemed to increase the severity of AA in this study (Table III) (6, 20) . Anti-BP line cells recovered from the thymus were found to be capable of mediating EAE in normal recipient rats. Thus, autoimmune, potential effector lymphocytes persisted in clinically well rats.
Another study involved rats that had acquired resistance to induction of a second attack of EAE subsequent to recovery from primary EAE induced by immunization to BP (21) . It was found that this form of acquired resistance too was associated with the appearance in the thymus, and less so in the spleen, of cells that specifically inhibited the proliferative responses in vitro of anti-BP effector T lymphocyte line cells. A function for the thymus in regulating EAE was also suggested by the finding that adult thymectomy of rats increased their susceptibility to progressive or relapsing EAE (22). Whatever the cellular mechanisms of resistance turn out to be, the present findings indicate that it is feasible using T lymphocyte line cells to manipulate the state of resistance to induction of what appears to be autoimmune arthritis. The clinical implication of these studies is clear (10, 19) .
